SynthesisEuropean journal of medical research2023

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.

Wenxue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.